JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A3291 CCT241533

Target: Chk

Summary: Potent Chk2 inhibitor

Soluble in DMSO
A8717 THZ2
1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK7 inhibitor

≥28.3 mg/mL
A3008 Y-27632 dihydrochloride
19 Citation

Target: ROCK

Summary: ROCK1 inhibitor

≥111.2 mg/mL
A4111 VX-680 (MK-0457,Tozasertib)

Target: Aurora Kinases

Summary: Aurora kinase inhibitor

≥23.25 mg/mL
A4112 Barasertib (AZD1152-HQPA)
3 Citation

Target: Aurora Kinases

Summary: Aurora Kinase B inhibitor, Potent and selective

≥25.4 mg/mL
A4113 ZM 447439

Target: Aurora Kinases|MEK|Src|Lck

Summary: Aurora Kinase inhibitor,potent and selective

≥25.7 mg/mL
A4114 MLN8054

Target: Aurora Kinases

Summary: Aurora A inhibitor

insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
A4115 JNJ-7706621
1 Citation

Target: Cyclin-Dependent Kinases|Aurora Kinases

Summary: Potent CDK/Aurora kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.7 mg/mL
A4118 Hesperadin
1 Citation

Target: Aurora Kinases

Summary: Aurora B kinase inhibitor

≥25.85 mg/mL
A4126 Aurora A Inhibitor I

Target: Aurora Kinases

Summary: Aurora A inhibitor

≥29.4 mg/mL